Letter to the Editor
Percutaneous Intervention of Left Main Coronary Artery Disease: A Fresh Look at a Class III Recommendation
AbstractPercutaneous intervention of left main coronary artery (LMCA) disease is a class III recommendation per the latest guidelines published by the American Heart Association/American College of Cardiology.1 As techniques, technologies, research, and pharmaceuticals advance, intervention on LMCA disease has become a more feasible option. We present two cases, both with different indications, but sharing a common conclusion.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view your purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.